Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Serge Y Fuchs

Showing results (31-40 of 118) with videos related to

Pageof 12
Sort By:
Molecular and Cellular Biology|April 15, 2004
Negative regulation of prolactin receptor stability and signaling mediated by SCF(beta-TrCP) E3 ubiquitin ligaseYing Li, K G Kuresh Kumar, Weigang Tang, et al.
Cancer Research|March 12, 2009
Impaired turnover of prolactin receptor contributes to transformation of human breast cellsAlexandr Plotnikov, Bentley Varghese, Thai H Tran, et al.
Nature Communications|May 14, 2016
miR-216b regulation of c-Jun mediates GADD153/CHOP-dependent apoptosisZhenhua Xu, Yiwen Bu, Nilesh Chitnis, et al.
Journal of the National Cancer Institute|August 5, 2004
Associations among beta-TrCP, an E3 ubiquitin ligase receptor, beta-catenin, and NF-kappaB in colorectal cancerAndrei Ougolkov, Bin Zhang, Kaname Yamashita, et al.
Journal of Virology|December 18, 2015
Hemagglutinin of Influenza A Virus Antagonizes Type I Interferon (IFN) Responses by Inducing Degradation of Type I IFN Receptor 1Chuan Xia, Madhuvanthi Vijayan, Curtis J Pritzl, et al.
Molecular Endocrinology (Baltimore, Md.)|October 22, 2010
Prolactin inhibits activity of pyruvate kinase M2 to stimulate cell proliferationBentley Varghese, Gayathri Swaminathan, Alexander Plotnikov, et al.
Cancer Research|March 9, 2005
Targeting beta-transducin repeat-containing protein E3 ubiquitin ligase augments the effects of antitumor drugs on breast cancer cellsWeigang Tang, Ying Li, Duonan Yu, et al.
Blood|August 12, 2011
Vascular endothelial growth factor-induced elimination of the type 1 interferon receptor is required for efficient angiogenesisHui Zheng, Juan Qian, Christopher J Carbone, et al.
Cancers|October 26, 2024
RNA Binding Proteins as Potential Therapeutic Targets in Colorectal CancerVikash Singh, Amandeep Singh, Alvin John Liu, et al.
The EMBO Journal|October 9, 2003
SCF(HOS) ubiquitin ligase mediates the ligand-induced down-regulation of the interferon-alpha receptorK G Suresh Kumar, Weigang Tang, Abhilash K Ravindranath, et al.
Pageof 12

Showing results (31-40 of 118) with videos related to

Sort By:
Pageof 12
Molecular and Cellular Biology|April 15, 2004
Negative regulation of prolactin receptor stability and signaling mediated by SCF(beta-TrCP) E3 ubiquitin ligaseYing Li, K G Kuresh Kumar, Weigang Tang, et al.
Cancer Research|March 12, 2009
Impaired turnover of prolactin receptor contributes to transformation of human breast cellsAlexandr Plotnikov, Bentley Varghese, Thai H Tran, et al.
Nature Communications|May 14, 2016
miR-216b regulation of c-Jun mediates GADD153/CHOP-dependent apoptosisZhenhua Xu, Yiwen Bu, Nilesh Chitnis, et al.
Journal of the National Cancer Institute|August 5, 2004
Associations among beta-TrCP, an E3 ubiquitin ligase receptor, beta-catenin, and NF-kappaB in colorectal cancerAndrei Ougolkov, Bin Zhang, Kaname Yamashita, et al.
Journal of Virology|December 18, 2015
Hemagglutinin of Influenza A Virus Antagonizes Type I Interferon (IFN) Responses by Inducing Degradation of Type I IFN Receptor 1Chuan Xia, Madhuvanthi Vijayan, Curtis J Pritzl, et al.
Molecular Endocrinology (Baltimore, Md.)|October 22, 2010
Prolactin inhibits activity of pyruvate kinase M2 to stimulate cell proliferationBentley Varghese, Gayathri Swaminathan, Alexander Plotnikov, et al.
Cancer Research|March 9, 2005
Targeting beta-transducin repeat-containing protein E3 ubiquitin ligase augments the effects of antitumor drugs on breast cancer cellsWeigang Tang, Ying Li, Duonan Yu, et al.
Blood|August 12, 2011
Vascular endothelial growth factor-induced elimination of the type 1 interferon receptor is required for efficient angiogenesisHui Zheng, Juan Qian, Christopher J Carbone, et al.
Cancers|October 26, 2024
RNA Binding Proteins as Potential Therapeutic Targets in Colorectal CancerVikash Singh, Amandeep Singh, Alvin John Liu, et al.
The EMBO Journal|October 9, 2003
SCF(HOS) ubiquitin ligase mediates the ligand-induced down-regulation of the interferon-alpha receptorK G Suresh Kumar, Weigang Tang, Abhilash K Ravindranath, et al.
Pageof 12